TSX · Medical Care Facilities · CAD
Healwell AI Inc. (AIDX.TO) Stock Analysis
Healwell AI Inc. (AIDX.TO) is a Medical Care Facilities stock listed on TSX and quoted in Canadian Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
AIDX.TO Key Statistics
As of Oct 21, 2026Trading
- Open
- CA$0.69
- Previous Close
- CA$0.69
- Day's Range
- 0.67–0.69
- 52-Week Range
- 0.58–1.55
- Volume
- 43.23K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- −0.96
Valuation
- Market Cap
- CA$227.36M
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.77
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.09
Financials (FY)
- Revenue (FY)
- CA$103.80M+426.62%
- Net Income (FY)
- −CA$47.11M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −23.01%
- Shares Outstanding
- 303.55M
- 1-Year Return
- −53.42%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 189.61K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, AIDX.TO closed at CA$0.68, −53.42% over 1 year.
Healwell AI Inc. (AIDX.TO) has a market capitalization of CA$227.36M.
In fiscal 2025, AIDX.TO reported revenue of CA$103.80M.
AIDX.TO Stock Return by Calendar Year
Healwell AI Inc. (AIDX.TO) return since Jan 2021: what CA$10,000 became
- 1 year
- CA$10,000 CA$4,658
- −53.42%
- 5 years
- CA$10,000 CA$3,505
- −64.95%
- Since Jan 2021
- CA$10,000 CA$1,504
- −84.96%
If you had invested CA$10,000 in Healwell AI Inc. (AIDX.TO) at the close on January 6, 2021, the earliest close on record here, it would have been worth CA$1,504 at the close on October 21, 2026: −84.96% in total, −27.91% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −19.05% |
| 2025 | −60.19% |
| 2024 | +181.33% |
| 2023 | +25.00% |
| 2022 | −52.00% |
| 2021 | −72.35% |
As of October 21, 2026.
AIDX.TO Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | CA$103.80M | −CA$47.11M | −45.4% |
| 2024 | CA$19.71M | −CA$26.29M | −133.4% |
| 2023 | CA$7.32M | −CA$31.60M | −431.8% |
| 2022 | CA$10.42M | −CA$21.09M | −202.3% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | CA$103.80M | CA$57.29M | −CA$29.53M | −CA$47.11M | −45.4% |
| 2024 | CA$19.71M | CA$10.82M | −CA$30.45M | −CA$26.29M | −133.4% |
| 2023 | CA$7.32M | CA$1.26M | −CA$16.82M | −CA$31.60M | −431.8% |
| 2022 | CA$10.42M | CA$3.71M | −CA$17.32M | −CA$21.09M | −202.3% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
AIDX.TO Valuation vs Medical Care Facilities Median
Median of 54 stocks| Metric | AIDX.TO | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/S ratio | 1.77 | 0.87 | 103% above |
| Profit margin | −23.01% | 3.19% | 26.2 pts below |
Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$99.46B
THCTenet Healthcare Corporation
$21.67B
EHCEncompass Health Corporation
$11.88B
FMSFresenius Medical Care AG
$11.47B
DVADaVita Inc.
$11.28B
UHSUniversal Health Services, Inc.
$10.78B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B